Globus Medical
GMED
73.75
-2.68
-3.51%
Globus Medical
US · GMED
#1454 by market cap
Listed 1970
73.75
-2.68
-3.51%
Live - 5344 symbols - heartbeat 74s ago
· 2026-10-08 07:49
Pre-market
73.59
-0.22%
After-hours
76.00
+3.05%
- Market cap
- 9.90B
- P/E (TTM)i
- 18.86
- P/Bi
- 2.08
- EPSi
- 3.92
- Div yieldi
- 0.00%
- 52W posi
- 38%
Reader sentiment
Are you bullish or bearish on GMED?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 13 analysts
Buy
Avg price target
98.75 +33.9%
Price target rangecurrent 73.75
Low82.00
Avg98.75
High117.00
Buy 69%
Hold 31%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | RBC Capital | -- | BUY | 85.00 |
| 2026-09-18 | BTIG | -- | HOLD | -- |
| 2026-08-28 | CCORF | -- | BUY | 115.00 |
| 2026-08-27 | Freedom Capital Markets | -- | HOLD | 87.00 |
| 2026-08-27 | BMO Capital | -- | BUY | 94.00 |
| 2026-08-19 | BofA Securities | -- | BUY | 106.00 |
| 2026-08-07 | Wells Fargo | -- | BUY | 99.00 |
| 2026-08-07 | Piper Sandler | -- | BUY | 100.00 |
| 2026-08-07 | BTIG | -- | HOLD | -- |
| 2026-08-07 | BofA Securities | -- | BUY | -- |
| 2026-08-07 | Truist Financial | -- | BUY | 100.00 |
| 2026-08-07 | Stifel | -- | HOLD | 85.00 |
| 2026-08-07 | Needham | -- | BUY | 117.00 |
| 2026-08-07 | BMO Capital | -- | BUY | 94.00 |
| 2026-08-06 | TD Cowen | -- | BUY | 115.00 |
| 2026-08-06 | CCORF | -- | BUY | 115.00 |
| 2026-08-06 | Wells Fargo | -- | BUY | 99.00 |
| 2026-07-28 | UBS | -- | HOLD | 82.00 |
| 2026-07-16 | Truist Financial | -- | BUY | 100.00 |
| 2026-07-10 | BTIG | -- | HOLD | -- |
| 2026-07-09 | BMO Capital | -- | BUY | 94.00 |
| 2026-07-08 | Stifel | -- | HOLD | 80.00 |
| 2026-06-22 | TD Cowen | -- | BUY | 115.00 |
| 2026-06-22 | BTIG | -- | HOLD | -- |
| 2026-06-15 | Piper Sandler | -- | BUY | 100.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Needham moved from Hold to Buy on 2026-01-30.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-01-30 | Needham | HOLD → BUY | 112.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±10.07% | +1.57% (in line) |
| 2026/Q1 | 2026-05-07 | After close | ±12.13% | -8.37% (in line) |
| 2025/Q4 | 2026-02-24 | After close | ±10.12% | +4.72% (in line) |
| 2025/Q3 | 2025-11-06 | After close | ±12.15% | +35.94% (beat) |
| 2025/Q2 | 2025-08-07 | After close | ±9.54% | +8.47% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±8.74% | -22.96% (beat) |
| 2024/Q4 | 2025-02-20 | After close | ±11.68% | -4.56% (in line) |
| 2024/Q3 | 2024-11-05 | After close | ±9.08% | +9.43% (beat) |
| 2024/Q2 | 2024-08-06 | After close | ±8.23% | +2.14% (in line) |
| 2024/Q1 | 2024-05-07 | After close | ±6.59% | +20.19% (beat) |
| 2023/Q4 | 2024-02-20 | After close | ±8.62% | +1.55% (in line) |
| 2023/Q3 | 2023-11-07 | After close | ±9.19% | -0.69% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:49:34 · For reference only, not investment advice and not tailored to your situation.